EP#528 - Jurgi Camblong: Decoding the Path to NASDAQ: The SOPHiA GENETICS Story
October 30, 2025
Co-produced by
Co-produced by
05:45 - From Scientist to Startup CEO
16:23 - Winning the Industries Trust With Data
28:33 - The Hidden Cost of Scaling Too Fast
47:31 - The Hard Truth About Going Public
Episode Summary:
Jurgi Camblong is the Co-Founder and CEO of SOPHiA GENETICS, a Swiss company using data-driven medicine to empower healthcare professionals worldwide. With a PhD in Molecular Biology from the Université de Genève, Jurgi transformed his deep scientific background into one of Switzerland’s few NASDAQ-listed success stories. SOPHiA GENETICS harnesses AI and advanced bioinformatics to make genomic and multimodal data accessible and actionable for hospitals all around the world.
In this episode, Jurgi shares how he founded SOPHiA GENETICS before AI became a buzzword, why timing and trust were everything when introducing cloud-based genomics to hospitals, and how a consumption-based business model helped the company stay customer-obsessed from day one. He also reflects on what it takes to educate a conservative industry, the importance of demonstrating value through accuracy, and why being early sometimes means having to build both the market and the product at once.
On a more personal level, Jurgi opens up about the challenges of scaling culture beyond 100 people, what he learned from taking SOPHiA GENETICS public on NASDAQ, and the emotional toll of entrepreneurship at that level. He talks about near-failures, resilience through crises, and why—after everything—he might never again build a company with more than 100 employees.
The cover portrait was edited by Smartportrait.
Don’t forget to give us a follow on Instagram, Linkedin, TikTok, and Youtube so you can always stay up to date with our latest initiatives. That way, there’s no excuse for missing out on live shows, weekly giveaways or founders' dinners.
